ESCALATION OF LIPID-LOWERING THERAPY IN PATIENTS WITH VASCULAR DISEASE AND LOWDENSITY LIPOPROTEIN CHOLESTEROL LEVELS BELOW 70MG/DL AFTER LOW TO MODERATE INTENSITY STATIN USE

被引：0
|
作者：
Park, Geunhee [1 ]
Park, Sungha [1 ]
Lee, Sang-Hak [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1316-219
引用
收藏
页码：1842 / 1842
页数：1
相关论文
共 32 条
  • [21] Moderate dose, three-drug therapy with Niacin, Lovastatin, and Colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease
    Brown, BG
    Bardsley, J
    Poulin, D
    Hillger, LA
    Dowdy, A
    Maher, VMG
    Zhao, XQ
    Albers, JJ
    Knopp, RH
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (02): : 111 - 115
  • [22] Impact of Baseline Low-Density Lipoprotein Cholesterol Level and Aggressive Lipid-Lowering Therapy by Ezetimibe on Prognosis of Statin Naive Acute Coronary Syndrome Patients: A Sub-Analysis of the HIJ-PROPER Trial
    Kawada-Watanabe, Erisa
    Yamaguchi, Junichi
    Sekiguchi, Haruki
    Im, Jihaeng
    Suzuki, Keisuke
    Ogiso, Masataka
    Arashi, Hiroyuki
    Ogawa, Hiroshi
    Hagiwara, Nobuhisa
    CIRCULATION, 2018, 138
  • [23] The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not At Goal study (SA-NAG)
    Ramjeeth, Akash
    Butkow, Neil
    Raal, Frederick
    Maholwana-Mokgatlhe, Mandisa
    CARDIOVASCULAR JOURNAL OF AFRICA, 2008, 19 (02) : 88 - 94
  • [24] Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease
    Takamiya, Yosuke
    Miura, Shin-Ichiro
    Kawamura, Akira
    Tanigawa, Hiroyuki
    Zhang, Bo
    Iwata, Atsushi
    Nishikawa, Hiroaki
    Matsuo, Kunihiro
    Shirai, Kazuyuki
    Saku, Keijiro
    CORONARY ARTERY DISEASE, 2009, 20 (04) : 288 - 294
  • [25] Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? - Data from a multicenter registry cohort study in Taiwan
    Yeh, Yen-Ting
    Yin, Wei-Hsian
    Tseng, Wei-Kung
    Lin, Fang-Ju
    Yeh, Hung-I
    Chen, Jaw-Wen
    Wu, Yen-Wen
    Wu, Chau-Chung
    PLOS ONE, 2017, 12 (10):
  • [26] Secondary prevention care and effect: Total and low-density lipoprotein cholesterol levels and lipid-lowering drug use in women and men after incident myocardial infarction - The TromsO Study 1994-2016
    Hopstock, Laila A.
    Eggen, Anne Elise
    Lochen, Maja-Lisa
    Mathiesen, Ellisiv B.
    Njolstad, Inger
    Wilsgaard, Tom
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2018, 17 (06) : 563 - 570
  • [27] Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD)
    Shaik, Aleesha
    Kosiborod, Mikhail
    de Lemos, James A.
    Gao, Qi
    Mues, Katherine E.
    Alam, Shushama
    Bhatt, Deepak L.
    Cannon, Christopher P.
    Ballantyne, Christie M.
    Rosenson, Robert S.
    CLINICAL CARDIOLOGY, 2022, 45 (12) : 1303 - 1310
  • [28] Intensity of Statin Therapy, Achieved Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Outcomes in Japanese Patients After Coronary Revascularization - Perspectives From the CREDO-Kyoto Registry Cohort-2
    Natsuaki, Masahiro
    Furukawa, Yutaka
    Morimoto, Takeshi
    Nakagawa, Yoshihisa
    Ono, Koh
    Kaburagi, Satoshi
    Inada, Tsukasa
    Mitsuoka, Hirokazu
    Taniguchi, Ryoji
    Nakano, Akira
    Kita, Tow
    Sakata, Ryuzo
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2012, 76 (06) : 1369 - 1379
  • [29] In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels &lt; 70 mg/dL and glycosylated hemoglobin A1c &lt; 7% are associated with lower major cardiovascular events
    White, Harvey D.
    Stewart, Ralph A. H.
    Dolby, Anthony J.
    Stebbins, Amanda
    Cannon, Christopher P.
    Budaj, Andrzej
    Linhart, Ales
    Pais, Prem
    Diaz, Rafael
    Steg, Philippe Gabriel
    Krug-Gourley, Sue
    Granger, Christopher B.
    Hochman, Judith S.
    Koenig, Wolfgang
    Harrington, Robert A.
    Held, Claes
    Wallentin, Lars
    AMERICAN HEART JOURNAL, 2020, 225 : 97 - 107
  • [30] Circulating Levels of Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Event Risk in Patients With Stable Coronary Artery Disease Treated With High-versus Low-Dose Pitavastatin in the Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease Trial
    Ishii, Junnichi
    Kashiwabara, Kosuke
    Takahashi, Hiroshi
    Nishimura, Hideto
    Kawai, Hideki
    Muramatsu, Takashi
    Harada, Masahide
    Yamada, Akira
    Hayashi, Mutsuharu
    Naruse, Hiroyuki
    Motoyama, Sadako
    Sarai, Masayoshi
    Watanabe, Eiichi
    Matsuyama, Yutaka
    Izawa, Hideo
    Ozaki, Yukio
    Nagai, Ryozo
    CIRCULATION, 2019, 140 (25) : E971 - E972
1234